Xu X - Search Results

1

Eosinophils promote pulmonary matrix destruction and emphysema via Cathepsin L.

Xu X, Yu T, Dong L, Glauben R, Wu S, Huang R, Qumu S, Chang C, Guo J, Pan L, Yang T, Lin X, Huang K, Chen Z, Wang C. Xu X, et al. Signal Transduct Target Ther. 2023 Oct 11;8(1):390. doi: 10.1038/s41392-023-01634-x. Signal Transduct Target Ther. 2023. PMID: 37816708 Free PMC article.

2

Correction: Eosinophils promote pulmonary matrix destruction and emphysema via Cathepsin L.

Xu X, Yu T, Dong L, Glauben R, Wu S, Huang R, Qumu S, Chang C, Guo J, Pan L, Yang T, Lin X, Huang K, Chen Z, Wang C. Xu X, et al. Signal Transduct Target Ther. 2023 Nov 27;8(1):438. doi: 10.1038/s41392-023-01698-9. Signal Transduct Target Ther. 2023. PMID: 38012133 Free PMC article. No abstract available.

3

Epithelium/imcDC2 axis facilitates the resistance of neoadjuvant anti-PD-1 in human NSCLC.

Chen Y, Shao Z, Hao Z, Xin Z, Chen X, Huang L, Chen D, Lin M, Liu Q, Xu X, Li J, Wu D, Yan J, Chai Y, Wu P. Chen Y, et al. Among authors: xu x. J Immunother Cancer. 2024 Aug 12;12(8):e007854. doi: 10.1136/jitc-2023-007854. J Immunother Cancer. 2024. PMID: 39134346 Free PMC article.

4

N-myc downstream regulated gene 1(NDRG1) promotes the stem-like properties of lung cancer cells through stabilized c-Myc.

Wang Y, Zhou Y, Tao F, Chai S, Xu X, Yang Y, Yang Y, Xu H, Wang K. Wang Y, et al. Among authors: xu x, xu h. Cancer Lett. 2017 Aug 10;401:53-62. doi: 10.1016/j.canlet.2017.04.031. Epub 2017 Apr 27. Cancer Lett. 2017. PMID: 28456659

5

A novel neutrophil extracellular traps-related lncRNA signature predicts prognosis in patients with early-stage lung adenocarcinoma.

Wang H, Shi Y, Xu X, Xu S, Shi Y, Chen W, Wang K. Wang H, et al. Among authors: xu s, xu x. Ann Med. 2023;55(2):2279754. doi: 10.1080/07853890.2023.2279754. Epub 2023 Nov 19. Ann Med. 2023. PMID: 37980632 Free PMC article.

6

Risk factors of immune checkpoint inhibitor-related pneumonitis after neoadjuvant immunochemotherapy for resectable NSCLC.

Mao Z, Pang G, Huang X, Chen X, Wu J, Xu X, Teng Z, Tan Y, Wang P. Mao Z, et al. Among authors: xu x. BMC Pulm Med. 2024 May 23;24(1):253. doi: 10.1186/s12890-024-03041-6. BMC Pulm Med. 2024. PMID: 38783253 Free PMC article.

7

Ca2+/calmodulin-dependent protein kinase IIγ enhances stem-like traits and tumorigenicity of lung cancer cells.

Chai S, Xu X, Wang Y, Zhou Y, Zhang C, Yang Y, Yang Y, Xu H, Xu R, Wang K. Chai S, et al. Among authors: xu r, xu x, xu h. Oncotarget. 2015 Jun 30;6(18):16069-83. doi: 10.18632/oncotarget.3866. Oncotarget. 2015. PMID: 25965829 Free PMC article.

8

KIF5B-RET fusion kinase promotes cell growth by multilevel activation of STAT3 in lung cancer.

Qian Y, Chai S, Liang Z, Wang Y, Zhou Y, Xu X, Zhang C, Zhang M, Si J, Huang F, Huang Z, Hong W, Wang K. Qian Y, et al. Among authors: xu x. Mol Cancer. 2014 Jul 21;13:176. doi: 10.1186/1476-4598-13-176. Mol Cancer. 2014. PMID: 25047660 Free PMC article.

9

Aldehyde dehydrogenases and cancer stem cells.

Xu X, Chai S, Wang P, Zhang C, Yang Y, Yang Y, Wang K. Xu X, et al. Cancer Lett. 2015 Dec 1;369(1):50-7. doi: 10.1016/j.canlet.2015.08.018. Epub 2015 Aug 28. Cancer Lett. 2015. PMID: 26319899 Review.

10

Correction to: KIF5B-RET fusion kinase promotes cell growth by multilevel activation of STAT3 in lung cancer.

Qian Y, Chai S, Liang Z, Wang Y, Zhou Y, Xu X, Zhang C, Zhang M, Si J, Huang F, Huang Z, Hong W, Wang K. Qian Y, et al. Among authors: xu x. Mol Cancer. 2019 Nov 19;18(1):164. doi: 10.1186/s12943-019-1093-0. Mol Cancer. 2019. PMID: 31739795 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56,958 results

Search Page

Filters